What is the latest AMRUTANJAN stock price?
The latest stored price for AMRUTANJAN is Rs 538.60 as of 2026-07-21.
gimli
AMRUTANJAN stock AI analysis
AMRUTANJAN Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
AMRUTAJAN HEALTH LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available AMRUTANJAN price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹538.60
1W return
+0.47%
1M return
-1.26%
3M return
-5.13%
6M return
-11.98%
1Y return
-22.40%
Market cap
₹1,556.56 cr
PE
26.88
PB
4.20
ROE
+16.62%
ROCE
+22.28%
RSI
47.23
Turnover
₹0.78 cr
Why it can matter in screens
- Momentum: AMRUTANJAN is below 50DMA, below 200DMA; RSI is 47.23.
- Returns: 1D -1.47%, 1W +0.47%, 1M -1.26%, 3M -5.13%, 1Y -22.40%.
- Trend levels: 52W high ₹768.35, 52W low ₹493.65, off high -29.90%.
- Liquidity: latest turnover is ₹0.78 cr; volume vs 20D is +0.22%.
- Valuation/profitability: PE 26.88, PB 4.20, ROE +16.62%, ROCE +22.28%.
- Growth: 3Y sales CAGR +9.93%, 3Y profit CAGR +13.29%.
Quick Answers
Is AMRUTANJAN above its 50DMA and 200DMA?
AMRUTANJAN is below 50DMA, below 200DMA. The latest 50DMA is 549.17 and the latest 200DMA is 610.98.
What are AMRUTANJAN PE, ROE and ROCE?
AMRUTANJAN has PE 26.88, ROE +16.62%, and ROCE +22.28% in Gimli's latest available snapshot.
How has AMRUTANJAN performed recently?
AMRUTANJAN has returned -1.26% over 1 month, -5.13% over 3 months, and -22.40% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 149.77 cr | 22.67 cr | 16.19 cr | 5.60 |
| 2025-12-31 | 141.04 cr | 28.04 cr | 19.45 cr | 6.73 |
| 2025-09-30 | 117.70 cr | 20.82 cr | 13.96 cr | 4.83 |
| 2025-06-30 | 94.05 cr | 12.87 cr | 8.31 cr | 2.87 |
| 2025-03-31 | 135.41 cr | 22.52 cr | 15.18 cr | 5.25 |
| 2024-12-31 | 122.75 cr | 27.71 cr | n/a | nan |
| 2024-09-30 | 109.92 cr | 17.65 cr | n/a | 4.08 |
| 2024-06-30 | 83.74 cr | 8.00 cr | 4.62 cr | 1.60 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 502.55 cr | 84.40 cr | 57.92 cr | nan |
| 2025-03-31 | 451.82 cr | 75.88 cr | 50.83 cr | 17.58 |
| 2024-03-31 | 420.12 cr | 68.16 cr | 44.97 cr | 15.50 |
| 2023-03-31 | 378.23 cr | 58.93 cr | 39.83 cr | 13.65 |
| 2022-03-31 | 421.22 cr | 94.86 cr | 67.19 cr | 23.00 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 508.89 cr | 11.27 cr | 1.78 cr | 370.23 cr |
| 2025-03-31 | 421.39 cr | 80.38 cr | 2.08 cr | 326.61 cr |
| 2024-03-31 | 366.87 cr | 25.76 cr | 1.73 cr | 288.49 cr |
| 2023-03-31 | 362.09 cr | 67.56 cr | 0.91 cr | 290.77 cr |
| 2022-03-31 | 349.87 cr | 83.48 cr | 0.88 cr | 265.12 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 35.97 cr | -19.04 cr | n/a |
| 2025-03-31 | 50.90 cr | 15.35 cr | n/a |
| 2024-03-31 | 27.91 cr | 21.19 cr | n/a |
| 2023-03-31 | 20.18 cr | 11.25 cr | n/a |
| 2022-03-31 | 52.20 cr | 28.73 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +46.52% | +2.44% | +12.28% | +5.82% | +38.72% | +0.00% |
| 2026-03-31 | +46.52% | +2.17% | +12.66% | +7.02% | +38.61% | +0.00% |
| 2025-12-31 | +46.52% | +2.27% | +13.00% | +7.55% | +38.18% | +0.00% |
| 2025-09-30 | +46.52% | +2.38% | +12.90% | +7.55% | +38.16% | +0.00% |
| 2025-06-30 | +46.52% | +2.41% | +12.70% | +7.55% | +38.33% | +0.00% |
| 2025-03-31 | +46.52% | +2.30% | +11.41% | +7.55% | +39.74% | +0.00% |
| 2024-12-31 | +46.52% | +2.30% | +11.12% | +9.21% | +40.02% | +0.00% |
| 2024-09-30 | +46.52% | +2.34% | +10.60% | +9.21% | +40.50% | +0.00% |
| 2024-06-30 | +50.59% | +1.55% | +7.32% | +6.76% | +40.47% | +0.00% |
| 2024-03-31 | +50.59% | +1.38% | +7.29% | +6.79% | +40.68% | +0.00% |
| 2023-12-31 | +50.59% | +0.80% | +7.24% | +6.79% | +41.19% | n/a |
| 2023-09-30 | +50.59% | +0.75% | +7.10% | +6.79% | +41.39% | +0.00% |
| 2023-06-30 | +50.04% | +0.70% | +7.22% | +6.93% | +41.87% | +0.00% |
| 2023-03-31 | +50.04% | +0.68% | +7.18% | +6.92% | +41.93% | +0.00% |
| 2022-12-31 | +50.02% | +0.76% | +6.39% | +6.14% | +42.65% | +0.00% |
| 2022-09-30 | +50.02% | +0.87% | +6.30% | +6.06% | +42.63% | +0.00% |
| 2022-06-30 | +50.02% | +0.00% | +7.58% | n/a | n/a | +0.00% |
| 2022-03-31 | +50.02% | +0.00% | +7.57% | n/a | n/a | +0.00% |
| 2021-12-31 | +50.02% | +0.00% | +7.97% | n/a | n/a | n/a |
| 2021-09-30 | +50.02% | +0.00% | +8.47% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 470,725.53 cr | 40.938102 | +14.71% | +15.93% |
| DIVISLAB | DIVI S LABORATORIES LTD | 194,588.48 cr | 75.774332 | +16.19% | +9.60% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 170,600.17 cr | 78.872017 | +17.18% | +43.04% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,349.41 cr | 65.537894 | +21.03% | +23.05% |
| CIPLA | CIPLA LTD | 115,717.42 cr | 29.815932 | +11.79% | -2.81% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 115,022.61 cr | 22.938459 | +17.93% | +17.85% |
| LUPIN | LUPIN LIMITED | 114,980.65 cr | 21.532280 | +26.83% | +30.91% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 107,095.75 cr | 74.247785 | +14.33% | -9.67% |
Try these prompts
- Analyze AMRUTAJAN HEALTH with valuation, momentum and industry peers
- Compare AMRUTANJAN with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare AMRUTANJAN with other Healthcare stocks
Data snapshot: 2026-07-21. Not investment advice.